Treating resistant Pseudomonas aeruginosa lung disease in young children with cystic fibrosis.

Authors :: Lim SZP
Fitzgerald DA
Source :: Paediatric respiratory reviews [Paediatr Respir Rev] 2018 Jun; Vol. 27, pp. 33-36. Date of Electronic Publication: 2017 Sep 01.
Publication Year :: 2018
Abstract: Pseudomonas aeruginosa is a common bacterial pathogen in the evolution of bronchiectasis in cystic fibrosis. The appearance of resistant strains of pseudomonas is increasing with the earlier and more liberal use of a range of anti-pseudomonal antibiotics for the treatment of bacterial chest infections. The rationale for treatment and potential benefits of aggressive treatment of resistant strains of Pseudomonas aeruginosa from early in life are discussed.<br /> (Copyright © 2017. Published by Elsevier Ltd.)

Subjects :: Anti-Bacterial Agents pharmacology
Child
Drug Resistance, Bacterial
Humans
Prognosis
Pseudomonas Infections etiology
Treatment Outcome
Cystic Fibrosis complications
Cystic Fibrosis diagnosis
Cystic Fibrosis microbiology
Pseudomonas Infections drug therapy
Pseudomonas aeruginosa drug effects
Pseudomonas aeruginosa isolation & purification
Pseudomonas aeruginosa pathogenicity

Full Text Access

Tools